The addition of an investigational therapeutic cancer vaccine to first-line pembrolizumab exhibited activity among patients ...

Hoarding may represent a misfiring of one of the brain’s oldest imperatives: to seek safety in connection. Where human bonds ...

Heart rate variability biofeedback (HRVB) can reduce negative affect, craving, and substance use among individuals in early recovery from substance use disorder (SUD).

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

COVID-19 was not associated with cognitive impairment in the first year after infection among middle-aged individuals.

Targeting prostate-specific membrane antigen, Lu-PSMA-617 has demonstrated clinical benefits in patients with PSMA-positive ...

Exelixis, Inc. reported STELLAR-303 trial results for zanzalintinib plus atezolizumab vs. regorafenib in mCRC. Learn more ...

Now four years into a first-in-class FDA approval for certain HR-positive, HER2-negative early breast cancers, Eli Lilly’s ...

The West has been preparing for and playing the wrong game with China – and that is why it is on the cusp of losing ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...

“DESTINY-Breast11 results support T-DXd [plus] THP as a more effective and less toxic neoadjuvant treatment compared with ddAC-THP, and it may become the preferred regimen for patients with high-risk, ...

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter. Life and ...